Holen Sie sich die Stockscreener-App
1.34
0.74%
-0.01
Vorhandelsmarkt:
1.29
-0.05
-3.73%
Schlusskurs vom Vortag:
$1.35
Offen:
$1.33
24-Stunden-Volumen:
109.33K
Relative Volume:
0.38
Marktkapitalisierung:
$3.46M
Einnahmen:
$294.20K
Nettoeinkommen (Verlust:
$-12.25M
KGV:
-0.2653
EPS:
-5.05
Netto-Cashflow:
$-10.77M
1W Leistung:
+11.67%
1M Leistung:
-15.19%
6M Leistung:
+117.25%
1J Leistung:
+225.48%
1-Tages-Spanne:
$1.30
$1.39
1-Wochen-Bereich:
$1.1822
$1.39
52-Wochen-Spanne:
$0.2375
$2.875
Aethlon Medical Inc Stock (AEMD) Company Profile
Firmenname
Aethlon Medical Inc
Sektor
Branche
Telefon
619-941-0360
Adresse
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Vergleichen Sie AEMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
1.34 | 2.41M | 294.20K | -12.25M | -10.77M | -5.05 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Fortgesetzt | H.C. Wainwright | Neutral |
Aethlon Medical Inc Aktie (AEMD) Neueste Nachrichten
What drives Aethlon Medical Inc. stock priceHigh-velocity gains - jammulinksnews.com
Is Aethlon Medical Inc. a good long term investmentUnmatched market performance - jammulinksnews.com
What analysts say about Aethlon Medical Inc. stockBreakthrough wealth creation - Autocar Professional
Aethlon Medical Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Financial Comparison: Aethlon Medical (NASDAQ:AEMD) versus Centene (NYSE:CNC) - Defense World
What makes Aethlon Medical Inc. stock price move sharplyTop Momentum Stock Pick - Newser
Why Aethlon Medical Inc. stock attracts strong analyst attentionEarly Buy Suggestion - Newser
How Aethlon Medical Inc. stock performs during market volatilityFree Elite Traders Group - Newser
Aethlon Medical advances to next cohort in cancer device trial - Investing.com Australia
Aethlon Medical advances to next cohort in cancer device trial By Investing.com - Investing.com Canada
Breakthrough: Cancer Treatment Device Clears Critical Safety Hurdle, Next Trial Phase Begins - Stock Titan
Aethlon Medical Reports Progress in Cancer Trials - TipRanks
Aethlon Medical Drops 13.1% After Reverse Split - AInvest
Aethlon Medical (NASDAQ:AEMD) Rating Increased to Neutral at HC Wainwright - Defense World
HC Wainwright Upgrades Aethlon Medical (NASDAQ:AEMD) to Neutral - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by HC Wainwright - Defense World
AEMD: HC Wainwright & Co. Sets New Price Target for Aethlon Medi - GuruFocus
Zacks Small Cap Predicts Aethlon Medical Q1 Earnings - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2025 Earnings Call Transcript - Insider Monkey
Aethlon Medical | 4: Statement of changes in beneficial ownership of securities-Director BROENNIMAN EDWARD G - 富途牛牛
AEMD Stock Plummets Following Disappointing Earnings | AEMD Stoc - GuruFocus
AEMD: Aethlon Reports $5.5M Cash Balance as of March 31 | AEMD Stock News - GuruFocus
Aethlon Medical's Hemopurifier: A Pivotal EV-Targeted Breakthrough in a Multibillion-Dollar Market - AInvest
Earnings call transcript: Aethlon Medical’s stock surges 23% post Q1 2025 call - Investing.com Canada
AETHLON MEDICAL Earnings Preview: Recent $AEMD Insider Trading, Hedge Fund Activity, and More - Nasdaq
Medical Device Pioneer Aethlon Medical Sets Q4 Earnings Date, Cancer Treatment Updates Expected - Stock Titan
Aethlon Medical (AEMD) Expected to Announce Quarterly Earnings on Thursday - Defense World
AEMD Reaches Milestone in Australian Hemopurifier Trial | AEMD Stock News - GuruFocus
Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial | AEMD Stock News - GuruFocus
Cancer Trial Breakthrough: Aethlon's Hemopurifier Shows Promise in Treating Therapy-Resistant Tumors - Stock Titan
Aethlon Medical at Emerging Growth Conference 83: Strategic Updates on Hemopurifier By Investing.com - Investing.com South Africa
Aethlon Medical at Emerging Growth Conference 83: Strategic Updates on Hemopurifier - Investing.com Nigeria
Finanzdaten der Aethlon Medical Inc-Aktie (AEMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):